Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × Lung Neoplasms × taletrectinib × Clear all

Status

No longer available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Thoracic Neoplasms 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Neoplasms by Site 1 Neoplasms 1 Lung Neoplasms 1 Lung Diseases 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Bronchogenic 1 Carcinoma 1

Interventions

trilaciclib 1 taletrectinib 1 lazertinib 1 dabrafenib 1 capmatinib 1 brigatinib 1 Suspensions 1 Powders 1 Paclitaxel 1 BID protein, human 1 AMG 757 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06841874 2025-12-24

Tale EAP

Nuvation Bio Inc.

No longer available

Carcinoma, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Site, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡